HCPCS Level IIdrugActive
J7188
Factor viii recomb obizur
BETOS: O1E
Effective: 2016-01-01
Referenced in 5 policies
Description
Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Obizur
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
1 IU
Billing Units
1.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.